Symbols

ELV

Elevance Health·NYSE

--(--)

ELV fundamentals

ELV Q4 2025 Earnings

Elevance Health (ELV) released its earnings on Jan 28, 2026: revenue was 49.31B (YoY +9.61%), missed estimates; EPS was 3.33 (YoY -13.28%), beat estimates.

Revenue / YoY

49.31B

+9.61%

EPS / YoY

3.33

-13.28%

Report date

Jan 28, 2026

ELV Earnings Call Summary for Q4,2025

2026 EPS Guidance: $25.50+ with 12%+ 2027 growth target, supported by diversified platform.
Medicaid Margin: -1.75% in 2026, actions to improve care coordination and reduce trend.
Medicare MA: 2%+ margin in 2026 despite 15-20% membership decline, driven by D-SNP focus.
Carelon Growth: Services up 60% in 2025, targeting mid-single-digit margin expansion.
Flu Impact: 20bps Q1 headwind embedded in guidance.
Policy Risks: Medicaid enrollment decline from eligibility checks, but manageable via program changes.

Earnings

EPS

Revenue

Revenue & Expenses

ELV has released its 2025 Q4 earnings report, with revenue of 49.75B, reflecting a YoY change of 9.47%, and net profit of 546.00M, showing a YoY change of 32.20%. The Sankey diagram below clearly presents ELV's revenue sources and cost distribution.

Key Indicators

Elevance Health (ELV) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Elevance Health (ELV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Elevance Health (ELV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Elevance Health (ELV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown